Glory Health Industry Balance Sheet Health

Finanzielle Gesundheit Kriterienprüfungen 2/6

Glory Health Industry hat ein Gesamteigenkapital von CN¥13.8B und eine Gesamtverschuldung von CN¥22.2B, was einen Verschuldungsgrad von 160.9% ergibt. Die Gesamtaktiva und Gesamtpassiva betragen CN¥56.4B bzw. CN¥42.6B.

Wichtige Informationen

161.3%

Verhältnis von Schulden zu Eigenkapital

CN¥22.13b

Verschuldung

Zinsdeckungsgrad	n/a
Bargeld	CN¥210.06m
Eigenkapital	CN¥13.72b
Gesamtverbindlichkeiten	CN¥41.36b
Gesamtvermögen	CN¥55.08b

Jüngste Berichte zur Finanzlage

Keine Aktualisierungen

Recent updates

Analyse der Finanzlage

Kurzfristige Verbindlichkeiten: 84RDie kurzfristigen Aktiva des Unternehmens (CN¥28.7B) decken seine kurzfristigen Passiva (CN¥28.9B) nicht.

Langfristige Verbindlichkeiten: 84RDie kurzfristigen Vermögenswerte des Unternehmens (CN¥29.7B) übersteigen seine langfristigen Verbindlichkeiten (CN¥12.9B).

Geschichte und Analyse des Verhältnisses von Schulden zu Eigenkapital

Verschuldungsgrad: 84RDie Nettoverschuldung im Verhältnis zum Eigenkapital (159.7%) wird als hoch angesehen.

Schulden abbauen: 84R Das Verhältnis von Schulden zu Eigenkapital ist in den letzten 5 Jahren von 161.5% auf 160.9% zurückgegangen.

Schuldendeckung: 84RDie Schulden des Unternehmens sind nicht ausreichend durch den operativen Cashflow (2.3%) gedeckt.

Zinsdeckung: Unzureichende Daten, um zu bestimmen, ob die Zinszahlungen von 84R für seine Schulden durch das EBIT gut gedeckt sind.

Glory Health Industry Balance Sheet Health

Finanzielle Gesundheit Kriterienprüfungen 2/6

Wichtige Informationen

Jüngste Berichte zur Finanzlage

Recent updates

Glory Health Industry Limited to Report First Half, 2024 Results on Aug 30, 2024

Glory Health Industry Limited, Annual General Meeting, Jun 28, 2024

Full year 2023 earnings released: CN¥0.13 loss per share (vs CN¥0.20 loss in FY 2022)

Glory Health Industry Limited to Report Fiscal Year 2023 Results on Mar 28, 2024

Glory Health Industry Limited Appoints Lam Yuen Ling Eva as Company Secretary

Glory Health Industry Limited Announces the Resignation of Liu Chengjiang as Independent Non-Executive Director, Chairman of the Internal Control Committee and Member of the Audit Committee

First half 2023 earnings released: CN¥0.06 loss per share (vs CN¥0.15 loss in 1H 2022)

Glory Health Industry Limited Announces Resignation of Lai Siming as an Independent Non-Executive Director

Glory Health Industry Limited to Report First Half, 2023 Results on Aug 31, 2023

Now 59% undervalued after recent price drop

Now 32% undervalued after recent price drop

Glory Health Industry Limited Announces Resignation of Kwong Yin Ping Yvonne as Joint Company Secretary and Authorised Representative, Effective July 1, 2023

Glory Health Industry Limited Announces Retirement of Luo Zhenbang as Independent Non-Executive Director

Glory Health Industry Limited Announces Resignation of Zheng Jin as Joint Company Secretary and an Authorised Representative

Glory Health Industry Limited, Annual General Meeting, Jun 30, 2023

Glory Health Industry Limited Appoints Liu Chengjiang as Independent Non-Executive Director, Chairman of Internal Control Committee and Member of Audit Committee

Now 21% undervalued after recent price drop

Full year 2022 earnings released: CN¥0.20 loss per share (vs CN¥0.051 profit in FY 2021)

Glory Health Industry Limited Announces Resignation of Ms. Chen Jingru as Independent Non-Executive Director, Chairman of the Internal Control Committee of the Company and Member of the Audit Committee

Less than half of directors are independent

First half 2022 earnings released: CN¥0.15 loss per share (vs CN¥0.06 profit in 1H 2021)

Glory Health Industry Limited Provides Earnings Guidance for Six Months Ended June 30, 2022

Glory Health Industry Limited to Report First Half, 2022 Results on Aug 31, 2022

Less than half of directors are independent

Full year 2021 earnings released: EPS: CN¥0.051 (vs CN¥0.022 in FY 2020)

Guorui Properties Limited to Report Fiscal Year 2021 Results on Mar 31, 2022

Less than half of directors are independent

First half 2021 earnings released: EPS CN¥0.06 (vs CN¥0.016 in 1H 2020)

Full year 2020 earnings released: EPS CN¥0.022 (vs CN¥0.19 in FY 2019)

Chairman & President recently bought €171k worth of stock

Full year 2020 earnings released: EPS CN¥0.022 (vs CN¥0.19 in FY 2019)

Guorui Properties Limited to Report Fiscal Year 2020 Results on Mar 31, 2021

Analyse der Finanzlage

Geschichte und Analyse des Verhältnisses von Schulden zu Eigenkapital

Bilanz

Entdecken Sie finanziell stabile Unternehmen